Prestige Consumer Healthcare Net Profit Margin 2010-2024 | PBH
Prestige Consumer Healthcare net profit margin from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Prestige Consumer Healthcare Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2024-03-31 | $1.13B | $0.21B | 18.58% |
| 2023-12-31 | $1.13B | $-0.08B | -7.14% |
| 2023-09-30 | $1.13B | $-0.08B | -7.28% |
| 2023-06-30 | $1.13B | $-0.09B | -7.52% |
| 2023-03-31 | $1.13B | $-0.08B | -7.36% |
| 2022-12-31 | $1.11B | $0.21B | 18.94% |
| 2022-09-30 | $1.11B | $0.21B | 18.79% |
| 2022-06-30 | $1.09B | $0.20B | 18.46% |
| 2022-03-31 | $1.09B | $0.21B | 18.88% |
| 2021-12-31 | $1.06B | $0.19B | 17.88% |
| 2021-09-30 | $1.02B | $0.18B | 17.61% |
| 2021-06-30 | $0.98B | $0.18B | 18.31% |
| 2021-03-31 | $0.94B | $0.17B | 17.60% |
| 2020-12-31 | $0.96B | $0.17B | 17.47% |
| 2020-09-30 | $0.96B | $0.16B | 17.10% |
| 2020-06-30 | $0.96B | $0.15B | 15.83% |
| 2020-03-31 | $0.96B | $0.14B | 14.75% |
| 2019-12-31 | $0.95B | $-0.03B | -3.57% |
| 2019-09-30 | $0.95B | $-0.03B | -3.57% |
| 2019-06-30 | $0.95B | $-0.04B | -3.78% |
| 2019-03-31 | $0.98B | $-0.04B | -3.69% |
| 2018-12-31 | $0.99B | $0.06B | 6.36% |
| 2018-09-30 | $1.02B | $0.34B | 33.33% |
| 2018-06-30 | $1.04B | $0.34B | 32.72% |
| 2018-03-31 | $1.04B | $0.34B | 32.63% |
| 2017-12-31 | $1.03B | $0.39B | 38.07% |
| 2017-09-30 | $0.97B | $0.11B | 11.10% |
| 2017-06-30 | $0.93B | $0.11B | 11.72% |
| 2017-03-31 | $0.88B | $0.07B | 7.81% |
| 2016-12-31 | $0.85B | $0.07B | 8.47% |
| 2016-09-30 | $0.83B | $0.07B | 8.16% |
| 2016-06-30 | $0.82B | $0.07B | 8.25% |
| 2016-03-31 | $0.81B | $0.10B | 12.41% |
| 2015-12-31 | $0.79B | $0.11B | 13.96% |
| 2015-09-30 | $0.79B | $0.10B | 13.10% |
| 2015-06-30 | $0.76B | $0.09B | 11.43% |
| 2015-03-31 | $0.72B | $0.08B | 10.91% |
| 2014-12-31 | $0.67B | $0.07B | 10.48% |
| 2014-09-30 | $0.62B | $0.05B | 8.46% |
| 2014-06-30 | $0.60B | $0.07B | 11.48% |
| 2014-03-31 | $0.60B | $0.07B | 12.21% |
| 2013-12-31 | $0.61B | $0.08B | 12.54% |
| 2013-09-30 | $0.62B | $0.09B | 13.69% |
| 2013-06-30 | $0.62B | $0.07B | 11.53% |
| 2013-03-31 | $0.62B | $0.07B | 10.48% |
| 2012-12-31 | $0.60B | $0.05B | 7.63% |
| 2012-09-30 | $0.55B | $0.04B | 8.01% |
| 2012-06-30 | $0.49B | $0.04B | 7.71% |
| 2012-03-31 | $0.44B | $0.04B | 8.62% |
| 2011-12-31 | $0.40B | $0.04B | 10.92% |
| 2011-09-30 | $0.39B | $0.04B | 9.28% |
| 2011-06-30 | $0.36B | $0.03B | 9.44% |
| 2011-03-31 | $0.34B | $0.03B | 8.63% |
| 2010-12-31 | $0.31B | $0.03B | 8.47% |
| 2010-09-30 | $0.29B | $0.04B | 12.07% |
| 2010-06-30 | $0.29B | $0.03B | 11.60% |
| 2010-03-31 | $0.29B | $0.03B | 10.92% |
| 2009-12-31 | $0.28B | $-0.18B | -64.31% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.300B | $1.125B |
| Prestige Consumer Healthcare Inc. is a consumer healthcare products company. Its diverse portfolio of brands include Monistat(R) and Summer's Eve(R) women's health products, BC(R) and Goody's(R) pain relievers, Clear Eyes(R) and TheraTears(R) eye care products, DenTek(R) specialty oral care products, Dramamine(R) motion sickness treatments, Fleet(R) enemas and glycerin suppositories, Chloraseptic(R) and Luden's(R) sore throat treatments and drops, Compound W(R) wart treatments, Little Remedies(R) pediatric over-the-counter products, Boudreaux's Butt Paste(R) diaper rash ointments, Nix(R) lice treatment, Debrox(R) earwax remover, Gaviscon(R) antacid in Canada, and Hydralyte(R) rehydration products and the Fess(R) line of nasal and sinus care products in Australia. Prestige Consumer Healthcare Inc., formerly known as Prestige Brands Holdings Inc., is based in Tarrytown, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $181.948B | 23.83 |
| Stryker (SYK) | United States | $126.472B | 30.29 |
| Medtronic (MDT) | Ireland | $112.493B | 15.93 |
| Boston Scientific (BSX) | United States | $109.225B | 34.79 |
| EssilorLuxottica (ESLOY) | France | $102.697B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.832B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.401B | 28.03 |
| ResMed (RMD) | United States | $32.412B | 30.43 |
| Terumo (TRUMY) | Japan | $26.228B | 37.04 |
| Koninklijke Philips (PHG) | Netherlands | $25.491B | 19.75 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.889B | 15.90 |
| Baxter (BAX) | United States | $18.054B | 12.84 |
| Insulet (PODD) | United States | $12.646B | 56.08 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.240B | 0.00 |
| Demant (WILYY) | Denmark | $10.234B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.583B | 28.08 |
| BellRing Brands (BRBR) | United States | $7.715B | 36.13 |
| Lantheus Holdings (LNTH) | United States | $5.517B | 13.75 |
| Haemonetics (HAE) | United States | $4.900B | 24.24 |
| GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
| Perrigo (PRGO) | Ireland | $4.120B | 12.49 |
| Envista Holdings (NVST) | United States | $3.241B | 13.38 |
| QuidelOrtho (QDEL) | United States | $3.011B | 16.71 |
| Neogen (NEOG) | United States | $2.881B | 27.71 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.816B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.741B | 54.29 |
| TG Therapeutics (TGTX) | United States | $2.739B | 77.04 |
| ICU Medical (ICUI) | United States | $2.546B | 22.47 |
| Agios Pharmaceuticals (AGIO) | United States | $1.997B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.858B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.752B | 51.36 |
| InMode (INMD) | Israel | $1.583B | 8.42 |
| Warby Parker (WRBY) | United States | $1.558B | 0.00 |
| Owens & Minor (OMI) | United States | $1.546B | 13.47 |
| AdaptHealth (AHCO) | United States | $1.308B | 9.74 |
| National Vision Holdings (EYE) | United States | $1.258B | 40.03 |
| BioLife Solutions (BLFS) | United States | $1.058B | 0.00 |
| AtriCure (ATRC) | United States | $1.053B | 0.00 |
| Canopy Growth (CGC) | Canada | $1.004B | 0.00 |
| Evolus (EOLS) | United States | $0.829B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.739B | 15.73 |
| Cresco Labs (CRLBF) | United States | $0.722B | 0.00 |
| Quanterix (QTRX) | United States | $0.684B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.639B | 15.02 |
| Valneva SE (VALN) | France | $0.616B | 0.00 |
| PetIQ (PETQ) | United States | $0.577B | 18.86 |
| Jin Medical (ZJYL) | China | $0.527B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.510B | 0.00 |
| Surmodics (SRDX) | United States | $0.479B | 29.96 |
| ZimVie (ZIMV) | United States | $0.455B | 38.79 |
| Biote (BTMD) | United States | $0.435B | 8.33 |
| OraSure Technologies (OSUR) | United States | $0.398B | 12.82 |
| Aurora Cannabis (ACB) | Canada | $0.388B | 0.00 |
| Cerus (CERS) | United States | $0.375B | 0.00 |
| Zynex (ZYXI) | United States | $0.350B | 47.87 |
| MacroGenics (MGNX) | United States | $0.295B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.294B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.269B | 26.61 |
| TriSalus Life Sciences (TLSI) | United States | $0.251B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.244B | 15.39 |
| Omeros (OMER) | United States | $0.242B | 0.00 |
| Veru (VERU) | United States | $0.215B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.204B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.200B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.170B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.169B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.156B | 75.00 |
| InterCure (INCR) | Israel | $0.149B | 25.23 |
| Jushi Holdings (JUSHF) | United States | $0.139B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 19.32 |
| Cellectar Biosciences (CLRB) | United States | $0.120B | 0.00 |
| Fonar (FONR) | United States | $0.103B | 8.84 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.097B | 0.00 |
| MariMed (MRMD) | United States | $0.095B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.092B | 0.00 |
| Brainsway (BWAY) | Israel | $0.090B | 0.00 |
| Chimerix (CMRX) | United States | $0.088B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.076B | 0.00 |
| Safety Shot (SHOT) | United States | $0.072B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.060B | 3.91 |
| Rockwell Medical (RMTI) | United States | $0.052B | 0.00 |
| Apyx Medical (APYX) | United States | $0.049B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.046B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 15.37 |
| Bright Green (BGXX) | United States | $0.040B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| Exagen (XGN) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Sharps Technology (STSS) | United States | $0.003B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |